Medicine containing polysaccharide substances for activating apoptosis
CA 2407504 A1 · Owner: Yvin, Jean-Claude · Inventors: Yvin, Jean-Claude; Arrigo, Andre Patrick
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the use of at least a polysaccharide substance having at least five saccharide units and comprising at least some single-unit motifs thereof at least a substituent bearing at least a negative charge selected among the group comprising in particular the sulphate acetate, phosphate, phosphonate groups for preparing a medicine for activating apoptosis by increasing the number of apoptosis receptors at the cell surface said receptors being those of the group comprising Fas TNF, TRAIL, CD40, preferably Fas and TNF receptors. Pathologies treated belong to the group of autoimmune diseases cancers and asthma, and the polysaccharide substance used is preferably sulphated …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.